HZ

5
Journal of Indian Academy of Oral Medicine and Radiology, January-March 2012;24(1):51-55 51 JIAOMR CASE REPORT Herpes Zoster: Report of a Treated Case with Review of Literature K Srikrishna, MPV Prabhat, Praveen Kumar Balmuri, S Sudhakar, D Ramaraju ABSTRACT Herpes zoster is a localized, generally painful cutaneous eruption that occurs most frequently among older adults and immunocompromized persons. It is caused by reactivation of latent varicella zoster virus (VZV). Approximately one in three persons will develop zoster during their lifetime. A common complication of zoster is postherpetic neuralgia (PHN), a chronic, often debilitating pain condition that can last months or even years. The risk for PHN in patients with zoster is 10 to 18%. Approximately 3% of patients with zoster are hospitalized. Death attributable to zoster are common among immunocompromized persons. Prompt treatment with the oral antiviral agents, corticosteroids and analgesics decreases the severity and duration of acute pain from zoster. This article reviews herpes zoster and reports one such case, which was treated successfully without any complications. Keywords: Herpes zoster, Varicella zoster, Shingles, Post herpetic neuralgia, Acyclovir, Corticosteroids. How to cite this article: Srikrishna K, Prabhat MPV, Balmuri PK, Sudhakar S, Ramaraju D. Herpes Zoster: Report of a Treated Case with Review of Literature. J Indian Aca Oral Med Radiol 2012;24(1):51-55. Source of support: Nil Conflict of interest: None declared INTRODUCTION Herpes zoster (HZ) also known as shingles, is an acute viral infection results from the reactivation of the DNA virus varicella zoster (VZV), which causes chickenpox. 1 It manifests as a painful vesicular rash which runs its course in a matter of 4 to 5 weeks. The pain may persist for months, even years, after the skin heals. This phenomenon is known as postherpetic neuralgia (PHN). 2 Herpes zoster can affect any of the three trigeminal branches, most commonly affecting the ophthalmic branch. The involvement of maxillary and mandibular branches without the involvement of ophthalmic branch is comparatively rare, which accounts for 1.7% of total cases of herpes zoster. 3 The aim of this article is to report one such rare case along with the review of herpes zoster. CASE REPORT A 49-year-old male patient reported to the department of oral medicine and radiology complaining of painful blisters over the left side of face since 3 days. The patient gave history of pain which was severe, continuous, radiating in 10.5005/jp-journals-10011-1259 nature and was associated with low-grade fever since 5 days. After 1 or 2 days, patient developed fluid-filled blisters over the left side of face. The blisters were initially small in size and few in number, later they increased in number by almost involving the entire left half of the face. The blisters were associated with watery discharge. Patient was not able to eat food and also not cleaning the mouth since 3 days. No relevant medical, dental and family history was reported by the patient. He had the habit of chewing areca nut in the form of gutkha for the past 20 years with a frequency of 15 packets per day. On general physical examination, the patient was found to be moderately built and nourished. No abnormality was detected IRT gait, nails, upper and lower limbs. No clinical signs of pallor, icterus, clubbing, cyanosis, edema and lymphadenopathy were present. On assessment of vital signs, temperature was noted to be 100°F and blood pressure 150/90 mm Hg. On extraoral examination, the patient had mesocephalic head (Fig. 1). No abnormality detected IRT eyes, nose, TMJ, salivary glands, paranasal sinuses. Numerous vesicles were present on the left preauricular, auricular and scalp of the temple region along with scar tissue in some areas (Fig. 2). Clusters of vesicles were also seen in left lower one-third of face, especially in the left perioral region with yellowish discharge (Figs 3 and 4). The skin was appearing swollen, shiny and the involved areas were very tender on palpation. On intraoral examination, left half of the lower lip was swollen, with few crustated areas. Multiple ulcers were seen on left buccal and lower labial mucosa, left retromolar area, left half of soft palate and on Fig. 1: Patient photograph

description

herpes zoster

Transcript of HZ

  • Journal of Indian Academy of Oral Medicine and Radiology, January-March 2012;24(1):51-55 51

    Herpes Zoster: Report of a Treated Case with Review of Literature

    JIAOMR

    CASE REPORT

    Herpes Zoster: Report of a Treated Case withReview of LiteratureK Srikrishna, MPV Prabhat, Praveen Kumar Balmuri, S Sudhakar, D Ramaraju

    ABSTRACT

    Herpes zoster is a localized, generally painful cutaneous eruptionthat occurs most frequently among older adults andimmunocompromized persons. It is caused by reactivation oflatent varicella zoster virus (VZV). Approximately one in threepersons will develop zoster during their lifetime. A commoncomplication of zoster is postherpetic neuralgia (PHN), a chronic,often debilitating pain condition that can last months or evenyears. The risk for PHN in patients with zoster is 10 to 18%.Approximately 3% of patients with zoster are hospitalized. Deathattributable to zoster are common among immunocompromizedpersons. Prompt treatment with the oral antiviral agents,corticosteroids and analgesics decreases the severity andduration of acute pain from zoster. This article reviews herpeszoster and reports one such case, which was treatedsuccessfully without any complications.

    Keywords: Herpes zoster, Varicella zoster, Shingles, Postherpetic neuralgia, Acyclovir, Corticosteroids.

    How to cite this article: Srikrishna K, Prabhat MPV,Balmuri PK, Sudhakar S, Ramaraju D. Herpes Zoster: Reportof a Treated Case with Review of Literature. J Indian Aca OralMed Radiol 2012;24(1):51-55.

    Source of support: Nil

    Conflict of interest: None declared

    INTRODUCTION

    Herpes zoster (HZ) also known as shingles, is an acute viralinfection results from the reactivation of the DNA virusvaricella zoster (VZV), which causes chickenpox.1 Itmanifests as a painful vesicular rash which runs its coursein a matter of 4 to 5 weeks. The pain may persist for months,even years, after the skin heals. This phenomenon is knownas postherpetic neuralgia (PHN).2 Herpes zoster can affectany of the three trigeminal branches, most commonlyaffecting the ophthalmic branch. The involvement ofmaxillary and mandibular branches without the involvementof ophthalmic branch is comparatively rare, which accountsfor 1.7% of total cases of herpes zoster.3 The aim of thisarticle is to report one such rare case along with the reviewof herpes zoster.

    CASE REPORT

    A 49-year-old male patient reported to the department oforal medicine and radiology complaining of painful blistersover the left side of face since 3 days. The patient gavehistory of pain which was severe, continuous, radiating in

    10.5005/jp-journals-10011-1259

    nature and was associated with low-grade fever since5 days. After 1 or 2 days, patient developed fluid-filledblisters over the left side of face. The blisters were initiallysmall in size and few in number, later they increased innumber by almost involving the entire left half of the face.The blisters were associated with watery discharge. Patientwas not able to eat food and also not cleaning the mouthsince 3 days. No relevant medical, dental and family historywas reported by the patient. He had the habit of chewingareca nut in the form of gutkha for the past 20 years with afrequency of 15 packets per day.

    On general physical examination, the patient was foundto be moderately built and nourished. No abnormality wasdetected IRT gait, nails, upper and lower limbs. No clinicalsigns of pallor, icterus, clubbing, cyanosis, edema andlymphadenopathy were present. On assessment of vitalsigns, temperature was noted to be 100F and blood pressure150/90 mm Hg.

    On extraoral examination, the patient had mesocephalichead (Fig. 1). No abnormality detected IRT eyes, nose, TMJ,salivary glands, paranasal sinuses. Numerous vesicles werepresent on the left preauricular, auricular and scalp of thetemple region along with scar tissue in some areas (Fig. 2).Clusters of vesicles were also seen in left lower one-thirdof face, especially in the left perioral region with yellowishdischarge (Figs 3 and 4). The skin was appearing swollen,shiny and the involved areas were very tender on palpation.

    On intraoral examination, left half of the lower lip wasswollen, with few crustated areas.

    Multiple ulcers were seen on left buccal and lower labialmucosa, left retromolar area, left half of soft palate and on

    Fig. 1: Patient photograph

  • K Srikrishna et al

    52JAYPEE

    the left lateral border of tongue extending upto ventralsurface (Figs 5 and 6). The ulcers were irregular in shapemeasuring approximately 10 5 mm in size witherythematous margins and sloping edges. The floor of theulcer showed yellowish white slough. The ulcers were tenderon palpation. No induration was noted. Fibrous bands werepalpable bilaterally on buccal mucosa. The oral hygienestatus of the patient was poor and was having manyperiodontally compromised teeth.

    Based on history, clinical findings, a provisionaldiagnosis of herpes zoster on left side of face involving2nd and 3rd branches of trigeminal nerve, chronicgeneralized periodontitis and oral submucous fibrosis wereconsidered.

    Patient was subjected for routine hematological andserological investigations. Complete blood picture wasfound to be within satisfactory limits except ESR, which wasslightly raised to 15 mm/1st hour. Cytological examinationwas performed after taking smear from the lesions present

    over left lower 1/3rd of face extraorally and left buccalmucosa intraorally. It revealed acantholytic cells with fewexfoliated squamous cells and inflammatory cells (Fig. 7).Upon correlating with the history, clinical findings andcytological examination the final diagnosis of herpes zosterwas given.

    The patient was then admitted in the hospital underphysicians opinion and was given hydration, supportiveand proper management. To start with, the patient was givenintravenous ringer lactate and dextrose normal saline (DNS).Antiviral therapy was started with acyclovir 800 mg tablets5 times per day for 10 days. Corticosteroids are given in theform of prednisolone 20 mg, twice daily. For pain controlpatient adviced to take paracetamol 500 mg tablets thricedaily. Betadine mouth wash was also given to improve oralhygiene. The patient was reviewed regularly.

    On examination of the patient after 1 week, there wasregression in the number of extraoral and intraoral lesionswith formation of scar tissue and hypopigmented areas

    Fig. 3: Vesicles present over the left lower 1/3rd of face

    Fig. 2: Vesicles present over the auricular and scalp of thetemple region

    Fig. 4: Unilateral distribution of lesions

    Fig. 5: Lesions present over the left buccal mucosa,left half of the lip

  • Journal of Indian Academy of Oral Medicine and Radiology, January-March 2012;24(1):51-55 53

    Herpes Zoster: Report of a Treated Case with Review of Literature

    JIAOMR

    from Greek word referring to a belt-like binding structureused by warriors to secure armor.2

    HZ is characterized by inflammation of dorsal rootganglia or extramedullary cranial nerve ganglia, associatedwith vesicular eruptions of the skin or mucous membranein an area supplied by the affected nerve.1 The mostcommonly affected dermatomes are the thoracic (45%),cervical (23%) and trigeminal (15%). The nerves mostcommonly affected in HZ are C3, T5, L1, L2 and the firstdivision of the trigeminal nerve. The incidence of HZincreases with age or immunosuppression. The predisposingfactors for reactivation of the virus are trauma, benign ormalignant tumor involving the dorsal root ganglia, localX-ray irradiation and immunosuppressive therapy.4,5

    Patients with HZ may progress through three stages:Prodromal stage, active or acute stage and chronic stage.6,7

    The prodromal stage presents as sensations like burning,tingling, itching, pricking and boring, occurring in cutaneous

    Fig. 6: Lesions present over the left ventrolateralsurface of tongue

    Fig. 7: Photomicrograph

    Fig. 9: Intraoral healed lesional areas

    Fig. 8: Extraoral healed lesional areas

    respectively (Figs 8 and 9). No fresh vesicles were found.The dose of the prednisolone was tapered to 10 mg. Thepatient was then discharged and recalled after 1 week. Thepatient was again reviewed after 2 weeks. On examinationtremendous improvement was noticed both extraorally andintraorally regarding the herpes zoster lesions. Fewpigmented areas were present over the skin correspondingto the previous lesions. Patient was asked to taper the doseof corticosteroids gradually and finally all the medicationswere stopped. The patient was further reviewed and treatedfor oral submucous fibrosis by using the combination ofcorticosteroids and hyaluronic acid intralesionally.

    REVIEW

    Herpes zoster (HZ) is the reactivated form of the varicellazoster virus (VZV). It is commonly known as Shingles,derived from the Latin word cingulum, meaning girdle.This is because a common presentation of herpes zosterinvolves unilateral rash that can wrap around the waist orchest, like a girdle. Similarly, the name zoster is derived

  • K Srikrishna et al

    54JAYPEE

    distribution of the dermatome and is believed to representviral degeneration of nerve fibrils.8 During this period, ifbranches of the trigeminal nerve are affected, odontalgiamay occur.9 In this condition, the reactivated virus maytravel along the length of the nerve, infect the pulpvasculature which leads to infarction and necrosis of pulp.8

    The symptoms of the prodromal stage may present up to1 month or for more duration before the acute mucocutanouslesions appear, posing diagnostic difficulties to the clinician.This is known as zoster sine herpete or zoster sineeruptione.8,9 The active stage is characterized by theemergence of the rash which is usually accompanied bysystemic upset. The characteristic skin rash progresses fromerythematous and edematous papules to vesicles and finallyresults in the formation of pustules within 1 to 7 days. Laterthe lesions may dry to form crustations, which will beexfoliated over 2 to 3 weeks leaving erythematous maculesthat may form scar. It may take several weeks for the skinto become normal. During the active phase the HZ will bemost contagious and could pose a significant cross infectionrisk. A child without prior contact with VZV can developchickenpox after contact with an individual with HZ. Thechronic stage is seen in approximately 10% of all patientswith HZ, and is termed as postherpetic neuralgia (PHN). Itis defined as a brief, recurrent, shooting, deep pain remainingfor over a month or 3 months after the healing of themucocutaneous lesions. It may persist for years and is asignificant cause of morbidity. Risk of occurrence ofpostherpetic neuralgia increases significantly after the ageof 60 years, which may be due to the decline in cell-mediatedimmunity.10 Although postherpetic neuralgia is the mostcommon complication of HZ, other complications like acuteretinal necrosis, encephalitis, myelitis, peripheral nervepalsies, contralateral hemiparesis can occur. Immuno-compromised individuals with HZ exhibit a significantlyhigher rate of complications. Periapical lesions, rootresorption, tooth exfoliation and alveolar osteonecrosis havealso been reported in association with HZ infection.11,12 Ifthe geniculate ganglion is involved, it may result in JamesRamsay Hunts syndrome, which includes facial paralysis,painful vesicular eruptions of external auditory meatus andpinna of the ear.13 HZ may also occasionally affect motornerves. HZ of the sacral region may cause paralysis of thebladder.

    The ophthalmic branch is affected several times morefrequently than the second or third divisions. Lesionsaffecting ophthalmic nerve usually involve lacrimal glands,conjunctiva, upper eyelid, forehead, scalp and root, lowerhalf of the nose. HZ of the first division can lead to blindnesssecondary to corneal scarring, which is known as herpeszoster ophthalmicus.14

    Table 1: Antiviral therapy for herpes zoster

    Medication Dosage

    Acyclovir 800 mg orally five times daily for 7 to 10 daysor 10 mg per kg IV every 8 hours for 7 to10 days

    Famciclovir 500 mg orally three times daily for 7 days Valacyclovir 1,000 mg orally three times daily for 7 days Brivudin 125 mg once daily for 7 days

    Facial and intraoral lesions are characteristic of HZinvolving the second and third divisions of the trigeminalnerve. Lesions affecting maxillary nerve involve mid face,scalp on the anterior part of the temporal region, lowereye lid, upper lip and lateral side of the nose.15 Lesionsaffecting the mandibular nerve involve lower face, tongueand lower lip.

    The history and clinical examination largely lead to thediagnosis, however for the confirmation, patients can besubjected for investigations like viral culture, antigendetection test by using modified Tzanck technique,Serological test via ELISA or latex agglutination,Polymerase chain reaction (PCR). PCR is useful to detectVZV DNA in body fluids, even when the patient is nothaving active infection.

    In majority of the patients herpes zoster is a self-limitingcondition and healing is usually complete. However, theactive management is indicated as follows: To reduce the acute symptoms of pain and malaise, To limit the spread and duration of the skin lesions and To prevent the development of postherpetic neuralgiaand ophthalmological complications in herpes zosterophthalmicus.

    Early diagnosis and prompt treatment of the disease inthe prodromal phase by the use of antiviral agents shouldbe the mainstay of its management.

    To start with, the patient should be isolated to preventthe transmission of the virus to healthy individuals. Keepthe cutaneous lesions clean and dry to reduce the risk forbacterial superinfection. The lesions should be protectedwith sterile, occlusive, nonadherent dressing and patientis instructed to wear loose fitting clothes for their comfort.If patient is not able to take proper diet, then he or sheshould be kept on intravenous fluids. Antiviral therapy(Table 1) has been shown to be very much beneficial indecreasing the duration of viral shedding, new lesionformation, severity of pain and accelerating the events ofcutaneous healing. However, these benefits have onlydemonstrated in patients who received antiviral agentswithin 72 hours after the onset of the rash.16 For effectivepain control short acting narcotic analgesics such asoxycodone can also be given.

  • Journal of Indian Academy of Oral Medicine and Radiology, January-March 2012;24(1):51-55 55

    Herpes Zoster: Report of a Treated Case with Review of Literature

    JIAOMR

    Orally administered corticosteroids are commonly usedin the treatment of herpes zoster, even though clinical trialshave shown variable results. Corticosteroids thought todecrease the degree of neuritis caused by active infection,resulting in the reduction of the residual damage to affectednerves. Prednisolone used in conjunction with acyclovir hasbeen shown to reduce the pain associated with herpeszoster.17 Oral corticosteroids can be used as 10 to 14 daystapering course of prednisolone, starting at 60 mg daily.

    CONCLUSION

    Herpes zoster of the trigeminal nerve is a disease that fallswithin the diagnostic purview of all dental specialists.A thorough knowledge of this disease will help in earlydiagnosis and prevents delayed treatment for the patient thusreducing the complications.

    REFERENCES1. Fristad I, Bardsen A, Knudsen GC, Molven O. Prodromal herpes

    zostera diagnostic challenge in endodontics. InternationalEndodontic Journal 2002;35:1012-16.

    2. Roxas M. Herpes zoster, postherpetic neuralgia. Diagnosis andtherapeutic considerations. Altern Med Rev 2006;11(2):102-13.

    3. Pattni N, Hudson P, Yates JM. Herpes zoster, odontalgia andnephropathy: A case report and review. Oral Surgery 2011;4:35-38.

    4. Schmader KE, Dworkin RH. Natural history and treatment ofherpes zoster. J Pain 2008;9:S3-9.

    5. Thomas SL, Hall AJ. What does epidemiology tell us aboutrisk factors for herpes zoster? Lancet Infect Dis 2004;4:26-33.

    6. Carmichael JK. Treatment of herpes zoster and postherpeticneuralgia. AmFam Physician 1991;44:203-10.

    7. Strommen GL, Pucino F, Tight RR, Beck CL. Human infectionwith H zoster: Etiology, pathophysiology, diagnosis, clinicalcourse and treatment. Pharmacotherapy 1988;8:52-68.

    8. Tidwell E, Hutson B, Burkhart N, Gutmann JL, Ellis CD. Herpeszoster of the trigeminal nerve third branch: A case report andreview of the literature. Int Endod J 1999;32:61-66.

    9. Gregory WB, Brooks LE, Penick EC. Herpes zoster associatedwith pulpless tooth. J Endod 1975;1:32-35.

    10. MacFarlane LL, Simmons MM, Hunter MH. The use ofcorticosteroids in the management of herpes zoster in childrenand adolescents. Pediatr Infect Dis J 1998;17:905-08.

    11. Ramchandani PL, Mellor TK. Herpes zoster associated withtooth resorption and periapical lesions. Br J Oral MaxillofacSurg 2007;45:71-73.

    12. Schwartz O, Kvorning SA. Tooth exfoliation, osteonecrosis ofthe jaw and neuralgia following herpes zoster of the trigeminalnerve. Int J Oral Surg 1982;1:364-71.

    13. Sun WL, Yan JL, Chen LL. Ramsay hunt syndrome withunilateral polyneuropathy involving cranial nerves V, VII, VIIIand XII in a diabetic patient. Quintessence Int 2011;42:873-77.

    14. Shaikh S, Ta CN. Evaluation and management of herpes zosterophthalmicus. Am Fam Physician 2002;66:1723-30.

    15. Liu CL, Lee JYY, Hsu MML, Chao SC, Wong TW, Sheu HM.The ocular complications of Herpes zoster ophthalmicusa study of Hutchinsons sign. Dermatol Sinica 1999;17:104-11.

    16. Stankus S, Dlugopolski M, Packer D. Management of herpeszoster (shingles) and postherpetic neuralgia. American familyphysician 2000;61(8):2437-44.

    17. Whitley RJ, Weiss H, Gnann J, Tyring S, Mertz GJ,Pappas PG, et al. Acyclovir with and without prednisone forthe treatment of herpes zoster. A randomized, placebo-controlledtrial. The national institute of allergy and infectious diseasescollaborative antiviral study group. Ann Intern Med 1996;125:376-83.

    ABOUT THE AUTHORS

    K Srikrishna

    Professor and Head, Department of Oral Medicine and RadiologyHazaribag Institute of Dental Sciences, Hazaribag, Jharkhand, India

    MPV Prabhat

    Professor, Department of Oral Medicine and Radiology, St JosephDental College, Eluru, Andhra Pradesh, India

    Praveen Kumar Balmuri (Corresponding Author)

    Reader, Department of Oral Medicine and Radiology, St Joseph DentalCollege, Eluru, Andhra Pradesh, India, e-mail: [email protected]

    S Sudhakar

    Reader, Department of Oral Medicine and Radiology, St Joseph DentalCollege, Eluru, Andhra Pradesh, India

    D Ramaraju

    Professor, Department of Oral Medicine and Radiology, SVS Instituteof Dental Sciences, Mahabubnagar, Andhra Pradesh, India